After a couple of years, arylcyclohexylamines, which were banned in the UK, are now back with 3-MeO-PCMo. This group of research chemicals had been banned by the UK Advisory Council on the Misuse of Drugs that outlawed members of this group, including Methoxetamine, which was put under a temporary ban in 2012, and the following year, arylcyclohexylamines became a Class B Drug.
Also called 4-[1-(3-methoxyphenyl) cyclohexyl] morpholine, 3-MeO-PCMo is an analogue of another research chemical, of 3-MeO-PCP.
While they may be chemically related, not much has been explored on the similarity of their effects, in doses including 100 mg. In a study, however, Methoxetamine (3-MeO-2-Oxo-PCE) required anywhere between 25 and 85 milligrams for achieving moderate effects.
So, what are the effects of 3-MeO-PCMo? According to experts, the effects can be dissociative anesthesia, especially when ingested. In this case, some users consume it for recreational purposes in the form of designer drugs.
At this point, however, a significant study exploring on the effects of this research chemical is yet to be concluded. Therefore, scientists and research chemist may be at an advantage to discovering and exploring into the potentials of the research chemical.
To give you a quick idea, we found something at Psychonaut Wiki revealing of the subjective effects of this drug. Take note, however, that the following effects don’t exist at once and may even vary from user to user, depending on dosage, body chemistry and tolerance.
For physical effects, some that are noted include spontaneous tactile sensation and decreased bodily weight as well as nausea and less motor control. It may also cause physical euphoria and physical autonomy. For its cognitive effects, users may experience derealization and depersonalization as well as time distortion and amnesia (in extreme cases of abuse). It may also cause suppression and visual disconnection.